[175] An observational study on people with obesity and type 2 diabetes and heart failure with preserved ejection fraction, semaglutide had about a 42% lower risk of hospitalization for heart failure and all-cause death combined compared with sitagliptin
Two novel dual GLP-1/GIP receptor agonists are neuroprotective in the MPTP mouse model of Parkinsons disease
Prices can differ based on the pharmacy, location, availability, and whether youre using insurance or paying out of pocket
This evidence challenges the conventional approach of delaying medication intervention and offers practitioners new options for tailoring obesity treatment to individual response patterns
Move your body regularly, including strength training
Were seeing giants like Unilever, Nestl and Danone weigh up gut health offerings to meet the market where its at, snacking and beverage companies fast losing share, and health-skewed fast-casual restaurants gaining ground